Table 1. Patient characteristics per treatment group
	Corifollitropin alfa	rFSH or HP-HMG	P
n	26	106
Age (years)	34.23±4.053	34.17±3.801	NS
Duration of stimulation (days)	11.92±1.896	11.87±2.168	NS
Age and duration of stimulation are expressed as means ± standard deviations; NS = not significant